Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 4, 2012, Pages 598-611

  Brait, Vanessa H ^a   Arumugam, Thiruma V ^b   Drummond, Grant R ^a   Sobey, Christopher G ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Immune system; ischemia; neurogenesis; reperfusion; stroke; T lymphocytes

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CYCLOSPORIN A; CYTOKINE; FINGOLIMOD; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 6; MIFEPRISTONE; NORADRENALIN; OXYGEN DERIVATIVE; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TACROLIMUS; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ADRENERGIC SYSTEM; ALLERGIC REACTION; AUTOIMMUNE DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; CD3+ T LYMPHOCYTE; CELL DEATH; ENDOTHELIUM CELL; HUMAN; HYPERACTIVITY; HYPOXEMIA; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IN VIVO STUDY; INFLAMMATION; LYMPHOID ORGAN; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; STROKE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THORAX DISEASE; URINARY TRACT INFECTION; VAGUS NERVE; VIRUS REPLICATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; BRAIN; BRAIN ISCHEMIA; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFECTION; INFLAMMATION; LYMPHOCYTE ACTIVATION; PITUITARY-ADRENAL SYSTEM; STROKE; T-LYMPHOCYTES;

EID: 84859425483     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.6     Document Type: Review

References (135)

1. Abbas AK, Lichtman AH (2011) Cell-mediated immune responses. In Basic Immunology Updated Edition: Functions and Disorders of the Immune System (Abbas AK, Lichtman AH, eds). 3rd edn. Philadelphia, PA: Saunders, pp 89-113
2. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787-93 (Pubitemid 26372655)
3. Andersson J, Libby P, Hansson GK (2010) Adaptive immunity and atherosclerosis. Clin Immunol 134:33-46
4. Appay V, Rowland-Jones SL (2001) RANTES: a versatile and controversial chemokine. Trends Immunol 22:83-7 (Pubitemid 32667526)
5. Arumugam TV, Granger DN, Mattson MP (2005) Stroke and T-cells. Neuromolecular Med 7:229-42 (Pubitemid 41507146)
6. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR (2004) Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol 11:49-53 (Pubitemid 38174922)
7. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway Jr CA (1993) Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177:57-68 (Pubitemid 23008085)
8. Barry M, Bleackley RC (2002) Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2:401-9 (Pubitemid 37328747)
9. Becker K, Kindrick D, McCarron R, Hallenbeck J, Winn R (2003) Adoptive transfer of myelin basic proteintolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury? Stroke 34:1809-15 (Pubitemid 36842650)
10. Becker K, Kindrick D, Relton J, Harlan J, Winn R (2001) Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32: 206-11 (Pubitemid 32063847)
11. Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM (1997) Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci USA 94:10873-8 (Pubitemid 27430828)
12. Bochelen D, Rudin M, Sauter A (1999) Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J Pharmacol Exp Ther 288:653-9 (Pubitemid 29119677)
13. Bornstein NM, Aronovich B, Korczyn AD, Shavit S, Michaelson DM, Chapman J (2001) Antibodies to brain antigens following stroke. Neurology 56:529-30 (Pubitemid 32172881)
14. Brait VH, Jackman KA, Walduck AK, Selemidis S, Diep H, Mast AE, Guida E, Broughton BRS, Drummond GR, Sobey CG (2010) Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J Cereb Blood Flow Metab 30:1306-17
15. Brait VH, Rivera J, Broughton BR, Lee S, Drummond GR, Sobey CG (2011) Chemokine-related gene expression in the brain following ischemic stroke: no role for CXCR2 in outcome. Brain Res 1372:169-79
16. Brecht S, Schwarze K, Waetzig V, Christner C, Heiland S, Fischer G, Sartor K, Herdegen T (2003) Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain. Neuroscience 120:1037-48 (Pubitemid 36966654)
17. Brecht S, Waetzig V, Hidding U, Hanisch UK, Walther M, Herdegen T, Neiss WF (2009) FK506 protects against various immune responses and secondary degeneration following cerebral ischemia. Anat Rec (Hoboken) 292:1993-2001
18. Cameron HA, McKay RD (2001) Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol 435:406-17 (Pubitemid 32574293)
19. Cerundolo V, Kronenberg M (2010) The role of invariant NKT cells at the interface of innate and adaptive immunity. Semin Immunol 22:59-60
20. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gomez-Choco M, Torres F, Planas AM (2007) Catecholamines, infection, and death in acute ischemic stroke. J Neurosci 252:29-35 (Pubitemid 44909185)
21. Chen H, Song YS, Chan PH (2009) Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J Cereb Blood Flow Metab 29:1262-72
22. Crack PJ, Taylor JM, Flentjar NJ, de Haan J, Hertzog P, Iannello RC, Kola I (2001) Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J Neurochem 78:1389-99 (Pubitemid 32899770)
23. Cramer SC, Chopp M (2000) Recovery recapitulates ontogeny. Trends Neurosci 23:265-71 (Pubitemid 30331113)
24. Czech B, Pfeilschifter W, Mazaheri-Omrani N, Strobel MA, Kahles T, Neumann-Haefelin T, Rami A, Huwiler A, Pfeilschifter J (2009) The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem Biophys Res Commun 389:251-6
25. Dambinova SA, Khounteev GA, Izykenova GA, Zavolokov IG, Ilyukhina AY, Skoromets AA (2003) Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem 49:1752-62 (Pubitemid 37194244)
26. Davis SM, Hand PJ, Donnan GA (2007) Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused. Med J Aust 187:548-9
27. D'Cruz LM, Yang CY, Goldrath AW (2010) Transcriptional regulation of NKT cell development and homeostasis. Curr Opin Immunol 22:199-205
28. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391-7 (Pubitemid 29453643)
29. Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T, Prass K, Meisel A (2007) Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 38:770-3 (Pubitemid 46184257)
30. Dziennis S, Mader S, Akiyoshi K, Ren X, Ayala P, Burrows GG, Vandenbark AA, Herson PS, Hurn PD, Offner HA (2011) Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab Brain Dis 26:123-33
31. Elvers M, Stegner D, Hagedorn I, Kleinschnitz C, Braun A, Kuijpers ME, Boesl M, Chen Q, Heemskerk JW, Stoll G, Frohman MA, Nieswandt B (2010) Impaired alpha(IIb)-beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal 3:ra1
32. Engelhardt B, Conley FK, Kilshaw PJ, Butcher EC (1995) Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1. Int Immunol 7:481-91
33. Frenkel D, Huang Z, Maron R, Koldzic DN, Moskowitz MA, Weiner HL (2005) Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci 233:125-32 (Pubitemid 40804828)
34. Gee JM, Kalil A, Thullbery M, Becker KJ (2008) Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke 39:1575-82
35. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T (2009) Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40:1849-57
36. Gendron A, Teitelbaum J, Cossette C, Nuara S, Dumont M, Geadah D, du Souich P, Kouassi E (2002) Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res 955:85-97 (Pubitemid 35284838)
37. Gerard C, Rollins BJ (2001) Chemokines and disease. Nat Immunol 2:108-15 (Pubitemid 33707927)
38. Glimcher LH, Murphy KM (2000) Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 14:1693-711 (Pubitemid 30602989)
39. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG (2007) Role of the Tcell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204:2449-60 (Pubitemid 47529329)
40. Harms H, Reimnitz P, Bohner G, Werich T, Klingebiel R, Meisel C, Meisel A (2011) Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis 32:552-60
41. Harrison DG, Guzik TJ, Goronzy J, Weyand C (2008) Is hypertension an immunologic disease? Curr Cardiol Rep 10:464-9
42. Hasegawa Y, Suzuki H, Sozen T, Rolland W, Zhang JH (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41:368-74
43. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, Janzen RW, Rother J, Buecker-Nott HJ, Berger K (2004) Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 164:1761-8 (Pubitemid 39215645)
44. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, Heiss WD (2003) Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 34:975-81 (Pubitemid 36402972)
45. Hug A, Liesz A, Muerle B, Zhou W, Ehrenheim J, Lorenz A, Dalpke A, Veltkamp R (2011) Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia. Stroke 42:3580-6
46. Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA, Offner H (2007) T-and B-celldeficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab 27:1798-805 (Pubitemid 47624547)
47. Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17:796-808
48. Iadecola C, Sugimoto K, Niwa K, Kazama K, Ross ME (2001) Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice. J Cereb Blood Flow Metab 21:1436-41 (Pubitemid 33117184)
49. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17:9157-64 (Pubitemid 27498443)
50. Ishikawa M, Cooper D, Russell J, Salter JW, Zhang JH, Nanda A, Granger DN (2003) Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 34:1777-82 (Pubitemid 36842645)
51. Ishikawa M, Zhang JH, Nanda A, Granger DN (2004) Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Front Biosci 9:1339-47 (Pubitemid 39060847)
52. Jackman KA, Miller AA, De Silva TM, Crack PJ, Drummond GR, Sobey CG (2009) Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br J Pharmacol 156:680-8
53. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS (2004) T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5:818-27 (Pubitemid 39172975)
54. Jander S, Kraemer M, Schroeter M, Witte OW, Stoll G (1995) Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab 15:42-51
55. Jander S, Pohl J, Gillen C, Schroeter M, Stoll G (1996) Vascular cell adhesion molecule-1 mRNA is expressed in immune-mediated and ischemic injury of the rat nervous system. J Neuroimmunol 70:75-80 (Pubitemid 26323570)
56. Justicia C, Martin A, Rojas S, Gironella M, Cervera A, Panes J, Chamorro A, Planas AM (2006) Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J Cereb Blood Flow Metab 26:421-32
57. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, Brandes RP (2007) NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38:3000-6 (Pubitemid 350035696)
58. Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH (1991) Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci USA 88:11158-62 (Pubitemid 21915999)
59. Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U, Meisel A, Meisel C (2009) Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 158:1184-93
60. Kleinschnitz C, De Meyer SF, Schwarz T, Austinat M, Vanhoorelbeke K, Nieswandt B, Deckmyn H, Stoll G (2009) Deficiency of vonWillebrand factor protects mice from ischemic stroke. Blood 113:3600-3
61. Kleinschnitz C, Grund H,Wingler K, Armitage ME, Jones E, Mittal M, Barit D, Schwarz T, Geis C, Kraft P, Barthel K, Schuhmann MK, Herrmann AM, Meuth SG, Stoll G, Meurer S, Schrewe A, Becker L, Gailus-Durner V, Fuchs H, Klopstock T, de Angelis MH, Jandeleit-Dahm K, Shah AM, Weissmann N, Schmidt HH (2010a) Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol 8:e1000479
62. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G (2007) Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 115:2323-30 (Pubitemid 46685900)
63. Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, Schwarz T, Austinat M, Nieswandt B,Wiendl H, Stoll G (2010b) Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 115:3835-42
64. Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, Chan PH (1997) Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci 17:4180-9 (Pubitemid 27220609)
65. Konoeda F, Shichita T, Yoshida H, Sugiyama Y, Muto G, Hasegawa E, Morita R, Suzuki N, Yoshimura A (2010) Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model. Biochem Biophys Res Commun 402:500-6
66. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485-517
67. Korpos E,Wu C, Song J, Hallmann R, Sorokin L (2010) Role of the extracellular matrix in lymphocyte migration. Cell Tissue Res 339:47-57
68. Kriz J (2006) Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol 18:145-57 (Pubitemid 350194068)
69. Kriz J, Lalancette-Hebert M (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117:497-509
70. Kunz A, Anrather J, Zhou P, Orio M, Iadecola C (2007) Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species. J Cereb Blood Flow Metab 27:545-51
71. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, Dick F, Taylor GS, Murray G (2000) Medical complications after stroke: a multicenter study. Stroke 31:1223-9 (Pubitemid 30351237)
72. Li JY, Furuichi Y, Matsuoka N, Mutoh S, Yanagihara T (2006) Tacrolimus (FK506) attenuates biphasic cytochrome c release and Bad phosphorylation following transient cerebral ischemia in mice. Neuroscience 142:789-97 (Pubitemid 44485917)
73. Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, Sun L, Hug A, Zorn M, Dalpke A, Nawroth P, Veltkamp R (2009a) The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 40:2849-58
74. Liesz A, Sun L, Zhou W, Schwarting S, Mracsko E, Zorn M, Bauer H, Sommer C, Veltkamp R (2011a) FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia. PLoS One 6:e21312
75. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R (2009b) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15:192-9
76. Liesz A, Zhou W, Mracsko E, Karcher S, Bauer H, Schwarting S, Sun L, Bruder D, Stegemann S, Cerwenka A, Sommer C, Dalpke AH, Veltkamp R (2011b) Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134: 704-20
77. Mackay CR (2001) Chemokines: immunology's high impact factors. Nat Immunol 2:95-101
78. Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, Vivien D (2011) Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol 10:471-80
79. Martin A, Aguirre J, Sarasa-Renedo A, Tsoukatou D, Garofalakis A, Meyer H, Mamalaki C, Ripoll J, Planas AM (2008) Imaging changes in lymphoid organs in vivo after brain ischemia with three-dimensional fluorescence molecular tomography in transgenic mice expressing green fluorescent protein in T lymphocytes. Mol Imaging 7:157-67
80. McCombe PA, Read SJ (2008) Immune and inflammatory responses to stroke: good or bad? Int J Stroke 3:254-65
81. McLachlan JB, Jenkins MK (2007) Migration and accumulation of effector CD4+ T cells in nonlymphoid tissues. Proc Am Thorac Soc 4:439-42 (Pubitemid 47435368)
82. Mehling M, Johnson TA, Antel J, Kappos L, Bar-Or A (2011) Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Neurology 76:S20-7
83. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U (2005) Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 6:775-86 (Pubitemid 41679240)
84. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, Schwartz M (2000) Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 15:331-45
85. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5:49-55 (Pubitemid 29050998)
86. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PH (1998) Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 18:205-13 (Pubitemid 28046782)
87. Nieswandt B, Kleinschnitz C, Stoll G (2011) Ischaemic stroke: a thrombo-inflammatory disease? J Physiol 589: 4115-23
88. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD (2006a) Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 26:654-65
89. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, Vandenbark AA, Hurn PD (2006b) Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176:6523-31 (Pubitemid 43787834)
90. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ (2003) The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 9:125-34 (Pubitemid 37310949)
91. Pfeilschifter W, Czech-Zechmeister B, Sujak M, Foerch C, Wichelhaus TA, Pfeilschifter J (2011a) Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice. Exp Transl Stroke Med 3:2
92. Pfeilschifter W, Czech-Zechmeister B, Sujak M, Mirceska A, Koch A, Rami A, Steinmetz H, Foerch C, Huwiler A, Pfeilschifter J (2011b) Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia. Biochem Biophys Res Commun 413: 212-7
93. Pham M, Helluy X, Kleinschnitz C, Kraft P, Bartsch AJ, Jakob P, Nieswandt B, Bendszus M, Stoll G (2011) Sustained reperfusion after blockade of glycoproteinreceptor-Ib in focal cerebral ischemia: an MRI study at 17.6 Tesla. PLoS One 6:e18386
94. Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV (2010) CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol 184:287-95
95. Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A (2006) Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 37:2607-12 (Pubitemid 44454686)
96. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198:725-36 (Pubitemid 37087772)
97. Purushothaman D, Sarin A (2009) Cytokine-dependent regulation of NADPH oxidase activity and the consequences for activated T cell homeostasis. J Exp Med 206:1515-23
98. Relton JK, Sloan KE, Frew EM, Whalley ET, Adams SP, Lobb RR (2001) Inhibition of alpha4 integrin protects against transient focal cerebral ischemia in normotensive and hypertensive rats. Stroke 32:199-205 (Pubitemid 32063846)
99. Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H (2011) CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab Brain Dis 26:87-90
100. Russell JH, Ley TJ (2002) Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20:323-70 (Pubitemid 34293428)
101. Saino O, Taguchi A, Nakagomi T, Nakano-Doi A, Kashiwamura S, Doe N, Nakagomi N, Soma T, Yoshikawa H, Stern DM, Okamura H, Matsuyama T (2010) Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke. J Neurosci Res 88:2385-97
102. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212:8-27 (Pubitemid 44116697)
103. Sampei K, Mandir AS, Asano Y, Wong PC, Traystman RJ, Dawson VL, Dawson TM, Hurn PD (2000) Stroke outcome in double-mutant antioxidant transgenic mice. Stroke 31:2685-91
104. Santana MA, Rosenstein Y (2003) What it takes to become an effector Tcell: the process, the cells involved, and the mechanisms. J Cell Physiol 195:392-401 (Pubitemid 36529867)
105. Schaller B, Graf R (2004) Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab 24:351-71 (Pubitemid 38452228)
106. Seder RA, Ahmed R (2003) Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 4:835-42 (Pubitemid 37098653)
107. Sharkey J, Butcher SP (1994) Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371:336-9 (Pubitemid 24300615)
108. Sharkey J, Crawford JH, Butcher SP, Marston HM (1996) Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. Stroke 27:2282-6 (Pubitemid 26427206)
109. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua DJ, Iwakura Y, Yoshimura A (2009) Pivotal role of cerebral interleukin-17-producing gdT cells in the delayed phase of ischemic brain injury. Nat Med 15:946-50
110. Smedbakken L, Jensen JK, Hallen J, Atar D, Januzzi JL, Halvorsen B, Aukrust P, Ueland T (2011) Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke. Stroke 42:2453-8
111. Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel-Poore MP (2002) The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res 932:110-9 (Pubitemid 34241600)
112. Stoll G, Kleinschnitz C, Nieswandt B (2010) Combating innate inflammation: a new paradigm for acute treatment of stroke? Ann NY Acad Sci 1207:149-54
113. Subramanian S, Zhang B, Kosaka Y, Burrows GG, Grafe MR, Vandenbark AA, Hurn PD, Offner H (2009) Recombinant T cell receptor ligand treats experimental stroke. Stroke 40:2539-45
114. Theodorou GL, Marousi S, Ellul J, Mougiou A, Theodori E, Mouzaki A, Karakantza M (2008) T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of stroke. Clin Exp Immunol 152:456-63 (Pubitemid 351661501)
115. Tracey KJ (2002) The inflammatory reflex. Nature 420: 853-9 (Pubitemid 36019638)
116. Tracey KJ (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117:289-96 (Pubitemid 46203953)
117. Uchino H, Elmer E, Uchino K, Li PA, He QP, Smith ML, Siesjo BK (1998) Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat. Brain Res 812:216-26 (Pubitemid 29005351)
118. Urra X, Cervera A, Villamor N, Planas AM, Chamorro A (2009) Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 158:1174-83
119. Vachon P, Beaudry F, Marier JF, Ste-Marie L, Montgomery J (2002) Cyclosporin A in blood and brain tissue following intra-carotid injections in normal and strokeinduced rats. Brain Res 943:1-8 (Pubitemid 34671167)
120. Vernino S, Brown Jr RD, Sejvar JJ, Sicks JD, Petty GW, O'Fallon WM (2003) Cause-specific mortality after first cerebral infarction: a population-based study. Stroke 34:1828-32 (Pubitemid 36944762)
121. Walder CE, Green SP, Darbonne WC, Mathias J, Rae J, Dinauer MC, Curnutte JT, Thomas GR (1997) Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 28:2252-8 (Pubitemid 27497931)
122. Wang WZ, Olsson T, Kostulas V, Hojeberg B, Ekre HP, Link H (1992) Myelin antigen reactive T cells in cerebrovascular diseases. Clin Exp Immunol 88:157-62
123. Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, Hwang SK, Guo S, Qin T, Alsharif N, Brinkmann V, Liao JK, Lo EH, Waeber C (2011) Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol 69:119-29
124. Weisbrot-Lefkowitz M, Reuhl K, Perry B, Chan PH, Inouye M, Mirochnitchenko O (1998) Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. Brain Res Mol Brain Res 53:333-8 (Pubitemid 28085473)
125. Wieloch T, Nikolich K (2006) Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 16:258-64 (Pubitemid 43949227)
126. Wolf SA, Steiner B, Akpinarli A, Kammertoens T, Nassenstein C, Braun A, Blankenstein T, Kempermann G (2009) CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J Immunol 182:3979-84
127. Wong CH, Jenne CN, Lee WY, Leger C, Kubes P (2011) Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334:101-5
128. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H (1994) Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25:165-70
129. Yilmaz G, Arumugam TV, Stokes KY, Granger DN (2006) Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113:2105-12
130. Yilmaz G, Granger DN (2008) Cell adhesion molecules and ischemic stroke. Neurol Res 30:783-93
131. Yilmaz G, Granger DN (2010) Leukocyte recruitment and ischemic brain injury. Neuromolecular Med 12:193-204
132. Yoshimoto T, Siesjo BK (1999) Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res 839:283-91 (Pubitemid 29416814)
133. Zhao BQ, Chauhan AK, Canault M, Patten IS, Yang JJ, Dockal M, Scheiflinger F, Wagner DD (2009) von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood 114:3329-34
134. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, Cohen H, Kipnis J, Schwartz M (2006) Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9:268-75 (Pubitemid 43164551)
135. Zouggari Y, Ait-Oufella H, Waeckel L, Vilar J, Loinard C, Cochain C, Recalde A, Duriez M, Levy BI, Lutgens E, Mallat Z, Silvestre JS (2009) Regulatory T cells modulate postischemic neovascularization. Circulation 120: 1415-25